Last reviewed · How we verify
NCT05520112
Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells
Phase 1, PHASE2 trial testing Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction in Recurrent Pregnancy Loss in 20 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 November 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Belarus |
Drugs / interventions tested
- Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction — full drug profile →
- Standard treatment according to the clinical protocols
Conditions studied
- Recurrent Pregnancy Loss — all drugs for Recurrent Pregnancy Loss →
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Who can join
Adults 18 to 49, female only, with Recurrent Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Treatment of Recurrent pregnancy loss using mesenchymal stem cells capable of differentiation in the endometrial-decidual direction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dual Role of Natural Killer Cells in Early Pregnancy: Immunopathological Implications and Therapeutic Potential in Recurrent Spontaneous Abortion and Recurrent Implantation Failure.
Guan D, Chen Z, Zhang Y, Sun W, et al · · 2025 · cited 7× · PMID 40325291 · DOI 10.1111/cpr.70037
Verify or expand the search:
- PubMed search for NCT05520112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Recurrent Pregnancy Loss
Currently open trials in the same condition.
- NCT06968026 — Effects of High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomi · NA · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
- NCT06182878 — Tender Loving Care for Recurrent Pregnancy Loss · NA · recruiting
- NCT05989178 — Prospective Recurrent Pregnancy Loss Registry · recruiting
- NCT06007560 — Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss · NA · active not recruiting
Other Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus trials
Trials by the same sponsor.
- NCT06167564 — Allergy Diagnostic Test Based on Microchip Technology · NA · unknown
- NCT05654766 — Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies · unknown
- NCT05520125 — Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles · Phase 1, PHASE2 · unknown
- NCT05214014 — Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells · Phase 1, PHASE2 · unknown
- NCT05187104 — Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells · Phase 1, PHASE2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05520112 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- Last refreshed: 29 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05520112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing